Erythema - 159 Studies Found

Completed : Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
: Discoid Lupus Erythematosus
: 2008-02-20
:
  • Drug: ASF 1096 0.5 % cream applied twice daily
Completed : Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
: Discoid Lupus Erythematosus
: 2008-01-23
:
  • Drug: Pimecrolimus 1% cream a

Terminated : Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
: Discoid Lupus Erthematosus of the Scalp.
: 2006-03-28
: Drug: Raptiva (efalizumab)
Completed : A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
: Discoid Lupus Erythematosus
: 1999-11-03
: Drug: Thalidomide
Completed : Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)
: Discoid Lupus Erythematosus
: 2008-02-20
:
  • Drug: ASF 1096 0.5 % cream
  • Drug: ASF 1096

Completed : The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
: Discoid Lupus Erythematosus (DLE)
: 2008-11-21
: Drug: etanercept(Enbrel®) etanercept(Enbrel®) 50mgs subcutaneous (SC) injections twice weekly
Completed : Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
:
  • Lupus Erythematosus, Discoid
  • Lupus Erythematosus, Cutaneous : 2016-01-08
    : Drug: Etanercept Treatment with etanercept is intended for remission induction of DLE only and not for m
Completed : Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)
:
  • Discoid Lupus Erythematosus
  • Systemic Lupus Erythematosus
    • <
    : 2017-05-02
    : Biological: Tofacitinib citrate 10 mg daily by mouth
Completed : A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
: Lupus Erythematosus, Discoid
: 2012-12-19
:
  • Drug: Belimumab 1 mg/kg Belimu
Completed : Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
: Discoid Lupus Erythematosus
: 2008-07-01
: Drug: CC-10004 20 mg twice daily by mouth for 12 weeks, followed by a 4 week washout period and final as
<<< Previous | Next >>>